Yahoo · Oct 26, 2026
Altria Q3 Earnings on the Horizon: Essential Insights for Investors
MO's third-quarter results are likely to show sales and earnings growth as pricing and nicotine pouch momentum offset lower cigarette volumes.
FR
NASDAQ · FRPT
Freshpet, Inc.
Consumer Defensive · Packaged Foods
$67.50
Up+$0.50 (+0.74%)
Updated Nov 2, 2026, 2:30 PM
SID Score
5.0/10
Composite research score
Smart Money
58/100
Neutral
- Market cap
- 3.07B
- P/E ratio
- 24.86
- Dividend yield
- 0.00%
- 52-week range
- $46.45 – $83.88
- Volume
- 1.13M
- Avg. volume
- 1.46M
Price performance · FRPT
FRPT price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 30, 2026
FRPT closed at $67.50 after 20 trading sessions, up 10.06% for the selected period.
- Last close
- $67.50
- Period change
- +10.06%
- Period low
- $61.33
- Period high
- $68.10
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 30, 2026 | $67.27 | $68.365 | $66.545 | $67.50 | 1.13M |
| Oct 29, 2026 | $66.06 | $66.775 | $65.43 | $66.12 | 847.01K |
| Oct 28, 2026 | $63.77 | $65.86 | $63.35 | $65.06 | 654.25K |
| Oct 27, 2026 | $64.70 | $64.71 | $63.64 | $64.38 | 684.29K |
| Oct 26, 2026 | $64.12 | $65.00 | $63.66 | $64.75 | 819.37K |
| Oct 23, 2026 | $67.01 | $67.01 | $64.00 | $64.12 | 616.46K |
| Oct 22, 2026 | $62.83 | $67.38 | $62.83 | $67.00 | 1.33M |
| Oct 21, 2026 | $65.06 | $65.515 | $62.43 | $62.58 | 1.07M |
| Oct 20, 2026 | $66.21 | $66.75 | $64.68 | $66.05 | 840.8K |
| Oct 19, 2026 | $65.86 | $66.415 | $65.00 | $66.12 | 644.87K |
| Oct 16, 2026 | $67.92 | $68.48 | $66.62 | $66.63 | 1.05M |
| Oct 15, 2026 | $68.97 | $69.58 | $67.27 | $67.65 | 886.73K |
| Oct 14, 2026 | $65.90 | $68.475 | $65.53 | $68.10 | 1.03M |
| Oct 13, 2026 | $65.26 | $67.115 | $64.4601 | $66.16 | 1.13M |
| Oct 12, 2026 | $64.08 | $65.57 | $60.15 | $65.26 | 1.29M |
| Oct 9, 2026 | $65.24 | $65.67 | $63.77 | $64.07 | 893.82K |
| Oct 8, 2026 | $63.25 | $65.56 | $62.915 | $65.18 | 1.39M |
| Oct 7, 2026 | $63.00 | $63.77 | $62.455 | $63.25 | 1.17M |
| Oct 6, 2026 | $61.45 | $63.78 | $61.44 | $62.77 | 1.43M |
| Oct 5, 2026 | $60.27 | $61.59 | $59.6894 | $61.33 | 1.02M |
Latest FRPT news
The latest Smart Investors Daily articles mentioning FRPT.
Stock researchCompany · Overview
Company
Market Activity
Research & News
FRPT research
Overview
Company profile and research snapshot.
Company profile
Freshpet produces and sells premium fresh pet food through its company-owned refrigerators placed in grocery, mass and club, pet specialty, and natural stores. Freshpet primarily targets dogs (96% of 2024 sales), with cats and treats comprising the rest of its sales. Geographically, the company's home US market, where all its food is produced, accounts for about 98% of sales, with exports to Canada, the United Kingdom, and other European countries accounting for the remaining balance.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- $60.40
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Oct 26, 2026 | JP Morgan | Overweight | — |
| Oct 13, 2026 | TD Cowen | Buy | — |
| Oct 5, 2026 | Wells Fargo | Overweight | — |
| Oct 1, 2026 | Needham | Hold | — |
| Aug 6, 2026 | Stifel | Buy | — |
News briefing
No generated briefing is available yet.
Yahoo · Oct 23, 2026
Freshpet (FRPT) Declines More Than Market: Some Information for Investors
Freshpet (FRPT) closed at $64.12 in the latest trading session, marking a -4.3% move from the prior day.
Yahoo · Oct 23, 2026
Medifast Q3 Earnings on the Horizon: Key Insights for Investors
MED's Q3 results are likely to face pressure from GLP-1 adoption, shrinking coach numbers and lower sales, while strategic initiatives may offer some support.
Yahoo · Oct 22, 2026
Wall Street Analysts Predict a 31.35% Upside in Freshpet (FRPT): Here's What You Should Know
The average of price targets set by Wall Street analysts indicates a potential upside of 31.4% in Freshpet (FRPT). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
